Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Surgical Research|February 7, 2016
Resident training in a new robotic thoracic surgery programYasmine N White, Priya Dedhia, Edward J Bergeron, et al.
BMJ Open Ophthalmology|August 4, 2023
Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX studyPaul Mitchell, Jennifer Arnold, Samantha Fraser-Bell, et al.
Ophthalmology|October 23, 2013
Intravitreal aflibercept for treatment-resistant neovascular age-related macular degenerationAndrew A Chang, Haitao Li, Geoffrey K Broadhead, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|November 12, 2025
Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical ConsequencesKimberly Leanne Spooner, Samantha Fraser-Bell, Hemal Mehta, et al.
Acta Ophthalmologica|February 12, 2019
Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degenerationKimberly Spooner, Thomas Hong, Rashmi Nair, et al.
BMJ Open Ophthalmology|March 14, 2024
Saffron therapy for the ongoing treatment of age-related macular degenerationGeoffrey K Broadhead, John Grigg, Peter J McCluskey, et al.
Ophthalmology. Retina|October 16, 2025
How to Judge Failure: Defining Treatment Resistance to Anti-VEGF Therapy in Exudative Maculopathies-A Systematic Scoping ReviewGeoffrey K Broadhead, Long Phan, Tiarnán D L Keenan, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 11, 2014
Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomesMeidong Zhu, Jamie K Chew, Geoffrey K Broadhead, et al.
Pageof 6